UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Hirayama disease. Clinical cases

Type of Article

In the Section

Abstract

Hirayama disease, or monomelic amyotrophy, is a rare neurological pathology manifested by unilateral or bilateral asymmetric paresis with atrophy of the distal upper extremities. The development of this disease is associated with the forward displacement of the posterior dural sac during neck flexion, which leads to compression of the spinal cord and venous stasis. The diagnosis of monomelic amyotrophy is based on the clinical picture and the results of magnetic resonance imaging of the cervical spine with flexion, showing segmental atrophy of the anterior horns of the spinal cord at C7 — Th1, detachment of the posterior dura mater and venous stasis. Most of the cases described in the literature are from India and Japan, with isolated cases diagnosed in North America and Europe.

This article presents two clinical cases of progressive hand weakness in young men. The clinical picture of the disease and the results of additional examination methods are presented, which is necessary to establish a diagnosis of Hirayama’s disease.

Pages

References

  1. Hirayama K. Non-progressive juvenile spinal muscular atrophy of the distal upper limb (Hirayama’s disease). In: Handbook of clinical neurology. Vol. 15. Amsterdam: Elsevier Science, 1991. P. 107—120.
  2. Hirayama K. Juvenile muscular atrophy of distal upper extremity (Hirayama disease) // Intern Med. 2000. No.  P. 283—290. DOI: https://doi.org/10.2169/internalmedicine.39.283.
  3. Hirayama K. Juvenile muscular atrophy of distal upper extremity (Hirayama disease): focal cervical ischemic poliomyelopathy // Neuropathology. 2000. Vol. 20, Issues 1. P. 91—94. DOI: https://doi.org/10.1046/j.1440-1789.2000.00305.x.
  4. Pradhan S. Magnetic resonance imaging in juvenile asymmetric segmental spinal muscular atrophy / S. Pradhan, R.    Gupta  // J  Neurol Sci, 1997. No.  146. P.  133—138. DOI: https://doi.org/10.1016/s0022-510x(96)00296-1.
  5. Gourie-Devi M. Long-term follow-up of 44 patients with brachial monomelic amyotrophy / M. Gourie-Devi, A. Nalini // Acta Neurol Scand. 2003. No. 107. P. 215—220. DOI: https://doi.org/10.1034/j.1600-0404.2003.02142.x.
  6. Hirayama K. Juvenile muscular atrophy of unilateral upper extremity: a new clinical entity / K. Hirayama, Y. Toyokura, T. Tsubaki // Psychiatry Neurol Jpn. 1959. No. 61. P. 2190—2198. DOI: https://ci.nii.ac.jp/naid/10007007676.
  7. Gouri-Devi M. Benign focal amyotrophy or monomelic amyotrophy / M. Gouri-Devi, T.  Suresh, S.  K. Shankar  // Arch Neurol, 1986 Apr. No.  43(12). P.  1223. DOI: https://doi.org/10.1001/archneur.1986.00520120009007.
  8. Clinical features of Hirayama disease in mainland China / [Zhou B., Chen L., Fan D., Zhou D.] // Amyotroph Lateral Scler. 2010. No. 11. P. 33—39. DOI: https://doi.org/10.3109/17482960902912407.
  9. Huang Y.-L. Hirayama Disease / Y.-L. Huang, C.-J. Chen // Neuroimag. Clin. N. Am. 2011. No. P.  939—950. DOI: https://doi.org/10.1016/j.nic.2011.07.009.
  10. Pradhan S. Bilaterally symmetric form of Hirayama disea se // Neurology. 2009. No. 72. P. 2083—2089. DOI: https://doi.org/10.1212/WNL.0b013e3181aa5364.
  11. Clinical profile of Monomelic Amyotrophy (MMA) and role of persistent viral infection / Vibha D., Behari M., Goyal V [et ] // Journal of  Clinical Neuroscience. 2015. No.  359. P. 4—7. DOI: https://doi.org/10.1016/j.jns.2015.10.026.
  12. Kira J. Juvenile muscular atrophy of the distal upper limb (Hirayama disease) associated with atrophy / J. Kira, H. Ochi // J. Neurosurg. Psychiatry. 2001. Vol. 70. P. 789—801. DOI: http://dx.doi.org/10.1136/jnnp.70.6.798.
  13. Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in  Japan  / Tashiro K., Kikuchi  , Itoyama  Y. [et  al]  // Amyotroph Lateral Scler. 2006. No.  7(1). P.  38—45. DOI:  https://doi.org/10.1080/14660820500396877.
  14. Hirayama K. Cervical dural sac and spinal cord in juvenile muscular atrophy of distal upper extremity / K. Hirayama, Y. Tokumaru // Neurology. 2000. No. P.  1922—1926. DOI: https://doi.org/10.1212/WNL.54.10.1922.
  15. MRI findings in Hirayama disease / Raval M., Kumari R., Dung A. [et  al.]  // Indian J  Radiol Imaging. 2010. No.  20. P. 245—249. DOI: https://doi.org/10.4103/0971-3026.73528.
  16. Angiographically proven cervical venous engorgement: a possible concurrent cause in the pathophysiology of Hirayama’s myelopathy / Ciceri E. F., Chiapparini L., Erbetta A. [et  ]  // Neurol Sci. 2010. No.  31. P.  845—848. DOI: https://doi.org/10.1007/s10072-010-0405-3.
  17. Exome sequencing identifies KIAA1377 and C5orf42 as susceptibility genes for monomelic amyotrophy / Lim Y. M., Koh , Park Y. M. [et  al.]  // Neuromuscul Disord. 2012 May. No.  22(5). P.  394—400. DOI:  https://doi.org/10.1016/j.nmd.2011.11.006.
  18. Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan Tashiro K., Kikuchi S., Itoyama Y. [et al.] // Amyotroph Lateral Scler. 2006 Mar. No. 7(1). P. 38—45. DOI: https://doi.org/10.1080/14660820500396877.
  19. Kieser David C., Cox P. J., Kieser, S. C. J. Hirayama disease // European Spine Journal. 2018. No. P. 1201—1206. DOI: https://doi.org/10.1007/s00586-018-5545-9.
  20. Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy  / Ammendola  , Gallo A., Iannaccone T. [et  al.]  // Neurol. Sci. 2008. No.  29. Р. 303—311. DOI: https://doi.org/10.1007/s10072-008-0987-1.
  21. Electrophysiology of juvenile muscular atrophy of unilateral upper limb (Hirayama’s disease) / Kuwabara S., Nakajima M., Hattori T. [et ] // Clin Neurol. 1999. No.  39. P.  508—512. https://europepmc.org/article/med/10424140. Forward shifting of posterior dural sac during flexion cervical magnetic resonance imaging in Hirayama disease: an initial study on normal subjects compared to patients with Hirayama disease / Lai V., Wong Y.  C., Poon W.  L. [et  al.]  // Eur  J  Radiol. 2011. No.  80. P. 724—872. DOI: https://doi.org/10.1016/j.ejrad.2010.07.021.
  22. Hirayama disease / Emma Foster, Benjamin K.-T. Tsang, Anthony Kamb [et ] // Journal of  Clinical Neuroscience. 2015. No.  22. P.  951—954. DOI: https://doi.org/10.1016/j.jocn.2014.11.025.
  23. Snake-eyes appearance on MRI occurs during the late stage of Hirayama disease and indicates poor prognosis / Xu H., Shao M., Zhang F. [et al.] // BioMed Res Int. 2019 Jan. Vol. 2019: Article ID 9830243. DOI: https://doi.org/10.1155/2019/9830243.
  24. Desai J. A Teaching Neuroimages: Anterior horn cell hyperintensity in Hirayama disease / J. A. Desai, M. Melanson // Neurology. 2011. No. 77  (12). DOI: https://doi.org/10.1212/WNL.0b013e31822f02d0.
  25. Hirayama disease / Lin   S., Kung W.  M., Chiu W. T. [et  al.]  // J  Neurosurg Spine. 2010. No.  12. P.  629—634. DOI: https://doi.org/10.3171/2009.12.SPINE09431.
  26. Pathophysiology and treatment for cervical flexion myelopathy / Fujimoto Y., Oka , Tanaka N. [et  al.]  // Eur. Spine J. 2002. No. 11. Р. 276—285. DOI: https://doi.org/10.1007/s005860100344.
  27. Hirayama disease: a frequently undiagnosed condition with simple inexpensive treatment / Verma R., Lalla R., Patil T. [et al.] // BMJ Case Reports. 2012. 007076. DOI: http://dx.doi.org/10.1136/bcr-2012-007076.